Effect of Verbascum cream on perineal pain intensity and episiotomy healing

Recruitment & Eligibility

Status: Complete

Sex: Female

Target Recruitment: 100

Inclusion Criteria

primiparous woman; Age between 18 to 35 years; living in the city of Saveh, Iran; At least having the ability to read and write; Non-smoking and drug abuse; Body mass index ranging from 18/5-30; Gestational age between 37 to 42 weeks; Single pregnancy with cephalic presentation; Newborn weight between 2500 to 4000 grams; Normal vaginal delivery without devices; Medio-lateral episiotomy with 4-3 cm length; Non infant hospitalization in the NICU; No have history of obstetric complications such as (preeclampsia and eclampsia, Gestational diabetes, Placental abruption, chorioamnionitis, premature rupture of memberanous more than 24 hours); No have severe anemia; Disorder of progression in time for the second stage of labor more than 14 hours more than 2 hours for the third stage more than half an hour; Non Diseases affecting wound healing (Chronic systemic disease, pulmonary disease, coagulation disorders, connective tissue, diabetes, anemia, immunodeficiency, hemophilia, malnutrition, mental disorders, renal failure); Consumption of drugs affecting wound healing (glucocorticoids, anti- coagulatives, anti- epileptic, immune system suppressants, antibiotics or chemotherapy agents); No have allergy to herbal drug; Lack of conflict between the family and the severe financial difficulties in recent months.

Exclusion criteria: Unwillingness to continue participating in the study; Lack of care for designated days; Do not use ointments regularly and as directed; Allergy to verbascum cream; Hematoma in the episiotomy after delivery; The need for perineal reconstruction after episiotomy; Fever and postpartum infection; Severe constipation after childbirth during the study; Hemorrhoids or anal fissure after delivery; Use betadine or sitzbath during the study; Having sex in the first 10 days after episiotomy
l

Exclusion Criteria

Not provided

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Wound healing of episiotomy. Timepoint: Before intervention,24 hours after delivery, 3 and 10 days after delivery. Method of measurement: REEDA scale.;Pain intensity. Timepoint: Before intervention,24 hours after delivery, 3 and 10 days after delivery. Method of measurement: Numerical Analouge Scale.

Secondary Outcome Measures

Name	Time	Method
Sedative tablets counting. Timepoint: 10 day after delivery. Method of measurement: questionnaire.;Common discontent after childbirth. Timepoint: 10 day after delivery. Method of measurement: questionnaire.